March 23, 2018 7:23 AM ET


Company Overview of Biosceptre International Limited

Company Overview

Biosceptre International Limited, a biotechnology company, develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. It develops a range of polyclonal, monoclonal, and domain antibodies for use in IVDs, topical therapeutics, in vivo imaging diagnostics, systemic therapeutics, and vaccines. The company was founded in 2000 and is based in North Ryde, Australia.

Suite 3.08

56 Delhi Road

North Ryde, NSW 2113


Founded in 2000


61 2 9889 1202


61 2 9887 4777

Key Executives for Biosceptre International Limited

Chief Executive Officer and Executive Director
Chief Medical Officer
Senior Manager of Legal and Compliance
Compensation as of Fiscal Year 2017.

Biosceptre International Limited Key Developments

Biosceptre International Limited Appoints Paul de Souza as Chief Medical Officer

Biosceptre announced that Professor Paul de Souza has accepted the role of Chief Medical Officer at the company. Initially, Dr. de Souza will provide guidance and insight on the Phase I clinical trial for Biosceptre's cancer vaccine product BIL06v. Professor Paul De Souza is Foundation Chair of Medical Oncology, School of Medicine, at Western Sydney University; a conjoint Professor in the Faculty of Medicine, UNSW; and an Honorary Professor of the NHMRC Clinical Trials Centre, University of Sydney. He has over 20 years' experience in caring for patients, especially those with brain cancer and genitourinary cancer, and clinical trials experience over the same period, including a stint as a Clinical Research Physician in a global research-based pharmaceutical company.

Biosceptre Appoints Sir Greg Winter as Interim Chairman

Biosceptre announced the appointment of Sir Greg Winter as interim Chairman of the Biosceptre Board. Sir Greg has led the Science Advisory Board of Biosceptre for over 4 years and also joined the Board of Directors as a non-executive director in May 2016.

Biosceptre International Limited Presents at 16th Annual Biotech in Europe Forum, Sep-28-2016 11:15 AM

Biosceptre International Limited Presents at 16th Annual Biotech in Europe Forum, Sep-28-2016 11:15 AM. Venue: MCH Messe Schweiz (Basel) AG, Messepl. 21, CH-4058 Basel, Switzerland. Speakers: Daniel Barton, Director of Business Development.

Similar Private Companies By Industry

Company Name Region
AbRegen Pty Ltd. Asia
Advanced Wound Care Pty Ltd. Asia
Agriliance Pty Ltd. Asia
AION Diagnostics Limited Asia
Aquaceutics Pty Ltd Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biosceptre International Limited, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at